JANX - Balance Sheet - Janux Therapeutics, Inc.

Current Liabilities	17.5 M
Accounts Payable	4.03 M
Short-Term Debt	1.75 M
Other Current Liabilities	11.7 M
Non-Current Liabilities	21.3 M
Long-Term Debt	0
Other Non-Current Liabilities	21.3 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	430.6	19.2	51.4	35.6	7.8	0.7
Short Term Investments	594.6	324.8	275.6	339.4	0	0
Receivables	0	0	0	0	8.0	0
Inventory	0	0	(0.7)	(0.2)	0	0
Other Current Assets	0	5.2	5.4	4.1	0.5	0
Total Current Assets	1 033.7	349.2	332.4	377.0	16.1	0.7
PP&E	24.1	27.8	29.4	1.6	0.2	21 K
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0.8	0.8	0	0
Other Long Term Assets	3.7	3.3	1.4	0.4	(0.2)	21 K
Other Assets	0	0	0	0	0	0
Total Assets	1 061.5	380.4	364.0	379.8	16.2	0.7
LIABILITIES
Accounts Payable	4.0	2.4	2.2	2.5	0.4	0.3
Short Term Debt	1.7	1.5	1.5	0.4	0	4.0
Other Current Liabilities	11.7	7.4	7.4	4.8	0.8	0.4
Total Current Liabilities	17.5	13.0	16.5	12.8	3.2	4.6
Long Term Debt	0	23.0	49.1	0	0	0
Deferred Tax Income	0	0	(2.2)	0	0	0
Other Liabilities	0	0	(24.5)	0	21.6	0
Total Liabilities	38.7	36.1	43.3	13.5	30.9	8.6
EQUITY
Common Stock	59 K	46 K	42 K	41 K	1 K	1 K
Retained Earnings	(237.8)	(168.8)	(110.5)	(47.4)	(14.7)	(8.0)
Other Accumulative Comprehensive Income/Loss	2.2	0.7	(1.5)	(0.3)	(21.6)	(4.0)
Total Equity	1 022.8	344.3	320.7	366.3	(14.6)	(7.9)
Total Liabilities and Equity	1 061.5	380.4	364.0	379.8	16.2	0.7
SHARES OUTSTANDING
Common Shares Outstanding	53.8	44.0	41.5	41.2	41.6	41.6

Free